Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme

Summary

RATIONALE: Giving boron phenylalanine in different ways and measuring it in tissue in patients with glioblastoma multiforme may help in planning better radiation therapy, such as boron neutron capture therapy, for patients in the future. PURPOSE: This phase I trial is studying the side effects, best dose boron phenylalanine, and best way of giving it with or without mannitol in treating patients with glioblastoma multiforme.

Timeline

Start

2007-10

Primary completion

2013-09

Completion

2013-09

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications